TRAX

First Tracks Biotherapeutics

NASDAQ: TRAX · HEALTHCARE · BIOTECHNOLOGY

$23.27

-1.57% today

Updated 2026-04-30

Market cap

$821.46M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.71

Dividend yield

—

52W range

$11 – $27

Volume

0.7M

Market cap

$821.46M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.71

Dividend yield

—

52W range

$11 – $27

Volume

0.7M

First Tracks Biotherapeutics (TRAX) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price

$23.27

12-Month target

—

2030 Target

—

Intrinsic (DCF)

—

Financial forecast

Metric
Revenue
EPS

CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.